Cindunistat

CAS No. 364067-22-1

Cindunistat( —— )

Catalog No. M36278 CAS No. 364067-22-1

Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 610 In Stock
10MG 867 In Stock
25MG 1302 In Stock
50MG 1721 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG 4557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cindunistat
  • Note
    Research use only, not for human use.
  • Brief Description
    Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.
  • Description
    Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    364067-22-1
  • Formula Weight
    219.3
  • Molecular Formula
    C8H17N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@](CSCCNC(C)=N)(C(O)=O)(C)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Iminobiotin

    2-Iminobiotin is a cyclic guanidino analog of biotin that acts as a reversible inhibitor of inducible nitric oxide synthase (iNOS) and neuronal NOS (nNOS;?Ki of 21.8 and 37.5 μM for mouse iNOS and rat nNOS respectively).

  • AR-C102222

    AR-C102222 is a potent, selective iNOS inhibitor with IC50 of 35 nM, dislapys 3,000-fold and 20-fold selectivity over eNOS and nNOS respectively; reduces inflammation produced by the application of arachidonic acid to the ear, attenuates FCA-induced mechanical hyperalgesia, and attenuates acetic acid-induced writhing in mice.Rheumatoid ArthritisDiscontinued

  • TP508

    TP508 is a 23 amino acid synthetic peptide representing residues 508-530 of human prothrombin which is identified as a potential receptor-binding domain based on competition for high-affinity thrombin binding to fibroblasts.TP508 (Chrysalin) is an investigational peptide drug that was developed for use in stimulating repair of dermal and musculoskeletal tissues.